An excerpt for the management of congenital portosystemic shunts and their complications: EASL expert consensus (2023)
10.3760/cma.j.cn501113-20240708-00317
- VernacularTitle:2023年欧洲肝病学会专家共识:先天性门体静脉分流及其相关并发症管理的专家意见(摘译)
- Author:
Na ZHANG
1
;
Guohong HAN
Author Information
1. 西安国际医学中心医院消化与外周血管介入科,西安 710100
- Keywords:
Portosystemic shunt;
Pulmonary hypertension;
Hepatocellular carcinoma;
Occlusion test;
Portal pressure
- From:
Chinese Journal of Hepatology
2024;32(11):965-969
- CountryChina
- Language:Chinese
-
Abstract:
This article is an excerpt from the Expert Management of Congenital Portosystemic Shunts and Their Complications, which was published by the European Association for the Study of the Liver (EASL). Some of the most challenging systemic complications that often associated with congenital portosystemic shunts (CPSS) are liver nodules, pulmonary hypertension, endocrine abnormalities, and neurocognitive dysfunction. This article mainly provides expert clinical guidance for the management of liver nodules, pulmonary hypertension, and endocrine abnormalities, along with recommendations for shunt closure and follow-up.